These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26483273)

  • 1. Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT).
    Landfeldt E; Mayhew A; Eagle M; Lindgren P; Bell CF; Guglieri M; Straub V; Lochmüller H; Bushby K
    Neuromuscul Disord; 2015 Dec; 25(12):937-44. PubMed ID: 26483273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric analysis of the pediatric quality of life inventory 3.0 neuromuscular module administered to patients with duchenne muscular dystrophy: A rasch analysis.
    Landfeldt E; Mayhew A; Straub V; Lochmüller H; Bushby K; Lindgren P
    Muscle Nerve; 2018 Sep; 58(3):367-373. PubMed ID: 29466827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysis.
    Landfeldt E; Mayhew A; Straub V; Bushby K; Lochmüller H; Lindgren P
    Disabil Rehabil; 2019 Apr; 41(8):966-973. PubMed ID: 29254382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.
    Mayhew A; Cano S; Scott E; Eagle M; Bushby K; Muntoni F;
    Dev Med Child Neurol; 2011 Jun; 53(6):535-42. PubMed ID: 21410696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasch analysis of the 32-item motor function measure in ambulant patients with Duchenne muscular dystrophy.
    Huang M; Chen T; Zhou C; Wang Y; Zeng H; Lu X; Cao J
    Clin Rehabil; 2023 Apr; 37(4):569-582. PubMed ID: 36285505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy.
    Landfeldt E; Iff J; Henricson E;
    Value Health; 2021 Oct; 24(10):1490-1498. PubMed ID: 34593173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks.
    Schwartz CE; Stark RB; Cella D; Borowiec K; Gooch KL; Audhya IF
    Orphanet J Rare Dis; 2021 Nov; 16(1):487. PubMed ID: 34809687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and content validation of the Muscular Dystrophy Child Health Index of Life with Disabilities questionnaire for children with Duchenne muscular dystrophy.
    Propp R; McAdam L; Davis AM; Salbach NM; Weir S; Encisa C; Narayanan UG
    Dev Med Child Neurol; 2019 Jan; 61(1):75-81. PubMed ID: 30058069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and Validity of the Korean Version of the Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool.
    Lee K; Hyun SE; Shin HI; Ji HM
    Ann Rehabil Med; 2023 Apr; 47(2):79-88. PubMed ID: 37070283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis.
    Landfeldt E; Alfredsson L; Straub V; Lochmüller H; Bushby K; Lindgren P
    Pharmacoeconomics; 2017 Feb; 35(2):249-258. PubMed ID: 27798808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales.
    Davis SE; Hynan LS; Limbers CA; Andersen CM; Greene MC; Varni JW; Iannaccone ST
    J Clin Neuromuscul Dis; 2010 Mar; 11(3):97-109. PubMed ID: 20215981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of the Chinese version of the Pediatric Quality Of Life InventoryTM (PedsQLTM) 3.0 neuromuscular module in children with Duchenne muscular dystrophy.
    Hu J; Jiang L; Hong S; Cheng L; Kong M; Ye Y
    Health Qual Life Outcomes; 2013 Mar; 11():47. PubMed ID: 23497421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a muscular dystrophy-specific functional rating scale.
    Lue YJ; Su CY; Yang RC; Su WL; Lu YM; Lin RF; Chen SS
    Clin Rehabil; 2006 Sep; 20(9):804-17. PubMed ID: 17005504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional assessment for people unable to walk due to spinal muscular atrophy and Duchenne muscular dystrophy. Translation and validation of the Egen Klassifikation 2 scale for the Spanish population].
    Fagoaga J; Girabent-Farrés M; Bagur-Calafat C; Febrer A; Steffensen BF
    Rev Neurol; 2015 May; 60(10):439-46. PubMed ID: 25952598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM.
    Klingels K; Mayhew AG; Mazzone ES; Duong T; Decostre V; Werlauff U; Vroom E; Mercuri E; Goemans NM;
    Dev Med Child Neurol; 2017 Feb; 59(2):224-231. PubMed ID: 27671699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of patients with Duchenne muscular dystrophy: from adolescence to young men.
    Lue YJ; Chen SS; Lu YM
    Disabil Rehabil; 2017 Jul; 39(14):1408-1413. PubMed ID: 27347814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL.
    Rowen D; Powell P; Mukuria C; Carlton J; Norman R; Brazier J
    Value Health; 2021 Oct; 24(10):1499-1510. PubMed ID: 34593174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the self-efficacy scale in caregivers of Duchenne muscular dystrophy patients.
    Türken A; Çapar H; Çakmak C; Kurt ME; Menteş N
    Work; 2024; 78(2):431-440. PubMed ID: 38143409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.